{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:05:08Z","timestamp":1789905908575,"version":"4.0.1"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"U.S. Centers for Disease Control and Prevention (CDC)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck and Company"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biologicals.2017.08.008","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T13:00:22Z","timestamp":1504357222000},"page":"3-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Eradicating hepatitis B virus: The critical role of preventing perinatal transmission"],"prefix":"10.1016","volume":"50","author":[{"given":"Cladd E.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearl","family":"Toy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Kamili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron J.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Liang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish N.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib1","doi-asserted-by":"crossref","first-page":"924","DOI":"10.7326\/0003-4819-66-5-924","article-title":"A\u00a0serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis","volume":"66","author":"Blumberg","year":"1967","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM197901183000301","article-title":"Viral hepatitis, type B. Studies on natural history and prevention re-examined","volume":"300","author":"Krugman","year":"1979","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.biologicals.2017.08.008_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM197504102921503","article-title":"Vertical transmission of hepatitis B antigen in Taiwan","volume":"292","author":"Stevens","year":"1975","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.biologicals.2017.08.008_bib4","first-page":"1389","article-title":"Hepatitis B antigen in infants born to mothers with chronic hepatitis B antigenemia in Taiwan","volume":"129","author":"Anderson","year":"1975","journal-title":"Am J Dis Child"},{"issue":"2","key":"10.1016\/j.biologicals.2017.08.008_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/146.2.198","article-title":"Incidence of hepatitis B virus in preschool children in Taiwan","volume":"146","author":"Beasley","year":"1982","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.biologicals.2017.08.008_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.1974.03230210013003","article-title":"Hepatitis B infection: a point-prevalence study in 15 U.S. hemodialysis centers","volume":"227","author":"Szmuness","year":"1974","journal-title":"J\u00a0Am Med Assoc"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jmv.1890040411","article-title":"Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols","volume":"4","author":"Szmuness","year":"1979","journal-title":"J\u00a0Med Virol"},{"issue":"2","key":"10.1016\/j.biologicals.2017.08.008_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/oxfordjournals.aje.a113532","article-title":"Incidence of hepatitis among students at a university in Taiwan","volume":"117","author":"Beasley","year":"1983","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to clinical expression of disease and subsequent development of the carrier state","volume":"151","author":"McMahon","year":"1985","journal-title":"J\u00a0Infect Dis"},{"issue":"7627","key":"10.1016\/j.biologicals.2017.08.008_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(69)90604-7","article-title":"Viral hepatitis, postnecrotic cirrhosis, and hepatocellular carcinoma","volume":"2","author":"Smith","year":"1969","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib11","first-page":"293","article-title":"Hepatitis B antigen, antigen subtypes and hepatitis B antibody in normal subjects and patients with liver disease","volume":"52","author":"Nishioka","year":"1975","journal-title":"Bull World Health Org"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ijc.2910160304","article-title":"A\u00a0case\/control study of the association between primary liver cancer and hepatitis B infection in Senegal","volume":"16","author":"Prince","year":"1975","journal-title":"Int J Cancer"},{"key":"10.1016\/j.biologicals.2017.08.008_bib13","first-page":"40","article-title":"Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal relationship","volume":"24","author":"Szmuness","year":"1978","journal-title":"Prog Med Virol"},{"issue":"8256","key":"10.1016\/j.biologicals.2017.08.008_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study in 22 707 men in Taiwan","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.biologicals.2017.08.008_bib15","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/1097-0142(19891201)64:11<2377::AID-CNCR2820641130>3.0.CO;2-8","article-title":"Maternal transmission and hepatitis B virus in childhood hepatocellular carcinoma","volume":"64","author":"Chang","year":"1989","journal-title":"Cancer"},{"issue":"5132","key":"10.1016\/j.biologicals.2017.08.008_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.8211155","article-title":"From hepatitis to hepatoma: lessons from type B viral hepatitis","volume":"262","author":"Chen","year":"1993","journal-title":"Science"},{"issue":"10049","key":"10.1016\/j.biologicals.2017.08.008_bib17","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990-2013: findings from the global burden of disease study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet"},{"issue":"9213","key":"10.1016\/j.biologicals.2017.08.008_bib18","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(00)02132-2","article-title":"Effect of hepatitis B virus mutants on efficacy of vaccination","volume":"355","author":"Zuckerman","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biologicals.2017.08.008_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00430-014-0373-y","article-title":"Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives","volume":"240","author":"Gerlich","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.biologicals.2017.08.008_bib20","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor of human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.biologicals.2017.08.008_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev-cellbio-100814-125241","article-title":"The hepatitis B virus receptor","volume":"31","author":"Li","year":"2015","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1 Suppl","key":"10.1016\/j.biologicals.2017.08.008_bib22","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jhep.2016.02.011","article-title":"Entry of hepatitis B and hepatitis D virus into hepatocytes: basic insights and ethical considerations","volume":"64","author":"Li","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.biologicals.2017.08.008_bib23","series-title":"Global health sector strategy on viral hepatitis 2016-2021","author":"World Health Organization (WHO)","year":"2016"},{"key":"10.1016\/j.biologicals.2017.08.008_bib24","series-title":"Global hepatitis report","author":"World Health Organization (WHO)","year":"2017"},{"key":"10.1016\/j.biologicals.2017.08.008_bib25","series-title":"Eliminating the public health problem of hepatitis B and C in the United States","author":"The National Academies of Sciences, Engineering, Medicine","year":"2016"},{"key":"10.1016\/j.biologicals.2017.08.008_bib26","series-title":"A\u00a0national strategy for the elimination of hepatitis B and C","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib27","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4049\/jimmunol.109.5.1017","article-title":"New specificities in Australia antigen-positive sera distinct from the Le Bouvier determinants","volume":"109","author":"Magnius","year":"1972","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.1975.03240160020020","article-title":"A\u00a0new antigen-antibody system. Clinical significance for long-term carriers of hepatitis B surface antigen","volume":"231","author":"Magnius","year":"1975","journal-title":"J\u00a0Am Med Assoc"},{"issue":"10003","key":"10.1016\/j.biologicals.2017.08.008_bib29","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2017.08.008_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2334-12-131","article-title":"The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions","volume":"12","author":"Ott","year":"2012","journal-title":"BioMed Cent Infect Dis"},{"issue":"10","key":"10.1016\/j.biologicals.2017.08.008_bib31","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J","article-title":"Hepatitis B virus. The major etiology of hepatocellular carcinoma","volume":"61","author":"Beasley","year":"1988","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","volume":"347","author":"Yang","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.biologicals.2017.08.008_bib33","first-page":"1059","article-title":"The carrier state in viral hepatitis","volume":"154","author":"Stokes","year":"1954","journal-title":"J\u00a0Am Med Assoc"},{"issue":"11","key":"10.1016\/j.biologicals.2017.08.008_bib34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM197009102831105","article-title":"Hepatitis-associated antigen (Australia antigen) in mother and infant","volume":"283","author":"Schweitzer","year":"1970","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.biologicals.2017.08.008_bib35","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jama.1972.03200080036009","article-title":"Hepatitis and hepatitis-associated antigen in 56 mother-infant pairs","volume":"220","author":"Schweitzer","year":"1972","journal-title":"J\u00a0Am Med Assoc"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0022-3476(97)80014-5","article-title":"Detection of maternofetal transfusion by placental alkaline phosphatase levels","volume":"130","author":"Kaneda","year":"1997","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib37","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1182\/blood.V88.4.1494.bloodjournal8841494","article-title":"Detection of maternal DNA in placental\/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene","volume":"88","author":"Scaradavou","year":"1996","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.biologicals.2017.08.008_bib38","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.1119541109","article-title":"Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect on cord blood transplantation","volume":"109","author":"van Rood","year":"2012","journal-title":"Proc Natl Acad Sci U. S. A."},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2005.02.030","article-title":"Developmental expression of canalicular transporter genes in human liver","volume":"43","author":"Chen","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/bdd.752","article-title":"Higher clearance of micafungin in neonates compared to adults: role of age-dependent micafungin serum binding","volume":"32","author":"Yanni","year":"2011","journal-title":"Biopharm Drug Dispos"},{"issue":"18","key":"10.1016\/j.biologicals.2017.08.008_bib41","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM197510302931823","article-title":"Letter: e antigen in HBs Ag-carrier mothers","volume":"293","author":"Schweitzer","year":"1975","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.biologicals.2017.08.008_bib42","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM197604012941402","article-title":"e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants","volume":"294","author":"Okada","year":"1976","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.biologicals.2017.08.008_bib43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/oxfordjournals.aje.a112370","article-title":"The e antigen and vertical transmission of hepatitis B surface antigen","volume":"105","author":"Beasley","year":"1977","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jmv.1890030310","article-title":"HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan","volume":"3","author":"Stevens","year":"1979","journal-title":"J\u00a0Med Virol"},{"issue":"6","key":"10.1016\/j.biologicals.2017.08.008_bib45","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/infdis\/170.6.1418","article-title":"Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load","volume":"170","author":"Burk","year":"1994","journal-title":"J\u00a0Infect Dis"},{"issue":"17","key":"10.1016\/j.biologicals.2017.08.008_bib46","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM197610212951701","article-title":"Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure","volume":"295","author":"Alter","year":"1976","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.biologicals.2017.08.008_bib47","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.1971.03190240019005","article-title":"Viral hepatitis, type B (MS-2 strain): prevention with specific hepatitis B immune serum globulin","volume":"218","author":"Krugman","year":"1971","journal-title":"J\u00a0Am Med Assoc"},{"issue":"15","key":"10.1016\/j.biologicals.2017.08.008_bib48","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1056\/NEJM197304122881503","article-title":"Viral hepatitis, type B (MS-2 strain). Further observations on natural history and prevention","volume":"288","author":"Krugman","year":"1973","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/infdis\/138.5.625","article-title":"Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multi-center controlled trial","volume":"138","author":"Grady","year":"1978","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-88-3-285","article-title":"Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study","volume":"88","author":"Seeff","year":"1978","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.biologicals.2017.08.008_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/infdis\/137.2.131","article-title":"Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis","volume":"137","author":"Prince","year":"1978","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biologicals.2017.08.008_bib52","series-title":"Viral hepatitis","first-page":"333","article-title":"Vertical transmission of HBV and interruption with globulin","author":"Beasley","year":"1978"},{"issue":"8243","key":"10.1016\/j.biologicals.2017.08.008_bib53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(81)90832-1","article-title":"Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomized double-blind placebo-controlled trial","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biologicals.2017.08.008_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hep.1840030201","article-title":"Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial","volume":"3","author":"Beasley","year":"1983","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biologicals.2017.08.008_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/147.2.185","article-title":"Postnatal infectivity of hepatitis B surface antigen-carrier mothers","volume":"147","author":"Beasley","year":"1983","journal-title":"J\u00a0Infect Dis"},{"issue":"15","key":"10.1016\/j.biologicals.2017.08.008_bib56","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM198010093031501","article-title":"Hepatitis B Vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States","volume":"303","author":"Szmuness","year":"1980","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biologicals.2017.08.008_bib57","series-title":"Viral hepatitis","first-page":"467","article-title":"Hepatitis B vaccine. A controlled clinical trial in homosexual men","author":"Szmuness","year":"1981"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib58","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/hep.1840010502","article-title":"A\u00a0controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report","volume":"1","author":"Szmuness","year":"1981","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib59","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-97-3-362","article-title":"The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men","volume":"97","author":"Francis","year":"1982","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.biologicals.2017.08.008_bib60","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJM198212093072403","article-title":"Hepatitis B vaccine in medical staff of hemodialysis unit: efficacy and subtype cross-protection","volume":"307","author":"Szmuness","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"8218","key":"10.1016\/j.biologicals.2017.08.008_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(81)91847-X","article-title":"Randomized, placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, medical staff","volume":"1","author":"Crosnier","year":"1981","journal-title":"Lancet"},{"issue":"8363","key":"10.1016\/j.biologicals.2017.08.008_bib62","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(83)91089-9","article-title":"Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial","volume":"2","author":"Desmyter","year":"1983","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biologicals.2017.08.008_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7326\/0003-4819-101-1-34","article-title":"Hepatitis B vaccine in health care personnel: safety, immunogenicity and indicators of efficacy","volume":"101","author":"Dienstag","year":"1984","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.biologicals.2017.08.008_bib64","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1001\/jama.1993.03510240043029","article-title":"Hepatitis B vaccine responsiveness in Connecticut public safety personnel","volume":"270","author":"Roome","year":"1993","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib65","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/infdis\/170.3.510","article-title":"Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or preS2+S antigens","volume":"170","author":"Clements","year":"1994","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.biologicals.2017.08.008_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-3797(98)00003-8","article-title":"Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection","volume":"15","author":"Averhoff","year":"1998","journal-title":"Am J Prev Med"},{"issue":"22","key":"10.1016\/j.biologicals.2017.08.008_bib67","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1001\/jama.1985.03360220053027","article-title":"Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine","volume":"254","author":"Weber","year":"1985","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib68","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1542\/peds.2009-1592","article-title":"Effect of needle length when immunizing obese adolescents with hepatitis B vaccine","volume":"125","author":"Middleman","year":"2010","journal-title":"Pediatrics"},{"issue":"8224","key":"10.1016\/j.biologicals.2017.08.008_bib69","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(81)92679-9","article-title":"Randomized placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: II, haemodialysis patients","volume":"1","author":"Crosnier","year":"1981","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biologicals.2017.08.008_bib70","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM198408233110803","article-title":"Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy","volume":"311","author":"Stevens","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib71","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0264-410X(96)00205-8","article-title":"Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule\u2013results of a post-marketing surveillance","volume":"15","author":"Clemens","year":"1997","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib72","first-page":"601","article-title":"Genetics of anti-HBs responsiveness","volume":"21","author":"Walker","year":"1981","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib73","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-105-3-356","article-title":"Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings","volume":"105","author":"Craven","year":"1986","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.biologicals.2017.08.008_bib74","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM198909143211103","article-title":"Genetic prediction of nonresponse to hepatitis B vaccine","volume":"321","author":"Alper","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib75","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.20142","article-title":"HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination","volume":"39","author":"Wang","year":"2004","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.biologicals.2017.08.008_bib76","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/hmg\/ddt586","article-title":"A\u00a0genomic-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations","volume":"23","author":"Pan","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.biologicals.2017.08.008_bib77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00430-014-0374-x","article-title":"Enhanced immune response to hepatitis B vaccination through immunization with a pre-S1\/pre-S2\/S vaccine","volume":"240","author":"Shouval","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.biologicals.2017.08.008_bib78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2015.06.008","article-title":"Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities","volume":"121","author":"Gish","year":"2015","journal-title":"Antivir Res"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib79","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/infdis\/148.3.526","article-title":"Immunogenicity of hepatitis B virus vaccine in healthy Chinese neonates","volume":"148","author":"Lee","year":"1983","journal-title":"J\u00a0Infect Dis"},{"issue":"46","key":"10.1016\/j.biologicals.2017.08.008_bib80","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1016\/j.vaccine.2014.08.078","article-title":"Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine","volume":"32","author":"Zhang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2017.08.008_bib81","series-title":"Viral hepatitis B infection in the Western Pacific region: vaccine and control","first-page":"163","article-title":"Current status of hepatitis B vaccination in children","author":"Beasley","year":"1984"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib82","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1542\/peds.70.4.613","article-title":"Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state","volume":"70","author":"Tada","year":"1982","journal-title":"Pediatrics"},{"issue":"8359","key":"10.1016\/j.biologicals.2017.08.008_bib83","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine","volume":"2","author":"Beasley","year":"1983","journal-title":"Lancet"},{"issue":"8383","key":"10.1016\/j.biologicals.2017.08.008_bib84","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(84)92388-2","article-title":"Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immune globulin. Double-blind randomized placebo-controlled study","volume":"1","author":"Wong","year":"1984","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.biologicals.2017.08.008_bib85","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.1985.03350360066020","article-title":"Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization","volume":"253","author":"Stevens","year":"1985","journal-title":"J\u00a0Am Med Assoc"},{"issue":"19","key":"10.1016\/j.biologicals.2017.08.008_bib86","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1001\/jama.1987.03390190090026","article-title":"Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission","volume":"257","author":"Stevens","year":"1987","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.biologicals.2017.08.008_bib87","series-title":"Viral hepatitis and hepatocellular carcinoma","first-page":"377","article-title":"Hepatitis B immune globulin and yeast-recombinant hepatitis B vaccine in prevention of perinatal HBV infection in the U.S.A","author":"Stevens","year":"1989"},{"issue":"1","key":"10.1016\/j.biologicals.2017.08.008_bib88","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12879-016-1754-1","article-title":"Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates","volume":"16","author":"Zhang","year":"2016","journal-title":"BioMed Cent Infect Dis"},{"issue":"21","key":"10.1016\/j.biologicals.2017.08.008_bib89","first-page":"285","article-title":"Postexposure prophylaxis of hepatitis B","volume":"33","author":"Centers for Disease Control and Prevention (CDC)","year":"1984","journal-title":"Morb Mortal Wkly Rep (MMWR)"},{"issue":"8711","key":"10.1016\/j.biologicals.2017.08.008_bib90","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0140-6736(90)91874-A","article-title":"Vaccine-induced escape mutant of hepatitis B virus","volume":"336","author":"Carman","year":"1990","journal-title":"Lancet"},{"issue":"7\u20138","key":"10.1016\/j.biologicals.2017.08.008_bib91","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0264-410X(98)00313-2","article-title":"The predicted pattern of emergence of vaccine-resistant hepatitis B: a cause for concern?","volume":"17","author":"Wilson","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib92","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.510300309","article-title":"Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus","volume":"30","author":"Ogata","year":"1999","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib93","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.22796","article-title":"Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model","volume":"49","author":"Kamili","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib94","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/JVI.68.4.2671-2676.1994","article-title":"Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen","volume":"68","author":"Yamamoto","year":"1994","journal-title":"J\u00a0Virol"},{"issue":"8","key":"10.1016\/j.biologicals.2017.08.008_bib95","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0264-410X(94)00080-7","article-title":"Molecular epidemiology of hepatitis B virus vaccine variants in Singapore","volume":"13","author":"Oon","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib96","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hep.510260336","article-title":"Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis","volume":"26","author":"Hsu","year":"1997","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib97","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.510300511","article-title":"Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan","volume":"30","author":"Hsu","year":"1999","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.biologicals.2017.08.008_bib98","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/gut.2003.034223","article-title":"Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan","volume":"53","author":"Hsu","year":"2004","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.biologicals.2017.08.008_bib99","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/651378","article-title":"No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents fully covered by universal infant immunization","volume":"201","author":"Hsu","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.biologicals.2017.08.008_bib100","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/infdis\/jis943","article-title":"Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant","volume":"207","author":"Hsu","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.biologicals.2017.08.008_bib101","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0166-0934(96)02077-0","article-title":"Sequence-specific, single-primer amplification and detection of PCR products for identification of hepatitis viruses","volume":"61","author":"Nainan","year":"1996","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.biologicals.2017.08.008_bib102","series-title":"Viral hepatitis and liver disease","first-page":"132","article-title":"Hepatitis B virus (HBV) antibody resistant mutants among mothers and infants with chronic HBV infection","author":"Nainan","year":"1996"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib103","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jmv.10206","article-title":"Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection","volume":"68","author":"Nainan","year":"2002","journal-title":"J\u00a0Med Virol"},{"issue":"6","key":"10.1016\/j.biologicals.2017.08.008_bib104","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000080872","article-title":"Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes","volume":"47","author":"Norder","year":"2004","journal-title":"Intervirology"},{"issue":"1","key":"10.1016\/j.biologicals.2017.08.008_bib105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cgh.2014.06.028","article-title":"Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and HBV genotype","volume":"13","author":"Ghany","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.biologicals.2017.08.008_bib106","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hep.24061","article-title":"Secular trend in the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization","volume":"53","author":"Wen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biologicals.2017.08.008_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165674","article-title":"Evaluation of the G145R mutant of hepatitis B virus as a minor strain in mother-to-child transmission","author":"Komatsu","year":"2016","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.biologicals.2017.08.008_bib108","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.biologicals.2017.08.008_bib109","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"issue":"18","key":"10.1016\/j.biologicals.2017.08.008_bib110","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1511691","article-title":"Benefits and risks of antiretroviral therapy for perinatal HIV prevention","volume":"375","author":"Fowler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.biologicals.2017.08.008_bib111","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3018(16)30195-3","article-title":"Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"4","author":"Uthman","year":"2017","journal-title":"Lancet HIV"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib112","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cgh.2012.01.019","article-title":"Telbivudine prevents vertical transmission for HBeAg-positive women with chronic hepatitis B","volume":"10","author":"Pan","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.biologicals.2017.08.008_bib113","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/hep.27837","article-title":"Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus","volume":"62","author":"Chen","year":"2015","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.biologicals.2017.08.008_bib114","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MEG.0000000000000793","article-title":"Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women","volume":"29","author":"Sellier","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.biologicals.2017.08.008_bib116","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12879-016-1734-5","volume":"16","author":"Jourdain","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.biologicals.2017.08.008_bib117","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/587695","article-title":"Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization","volume":"197","author":"Lu","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.biologicals.2017.08.008_bib118","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/INF.0b013e31817702ba","article-title":"Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study","volume":"27","author":"Bialek","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.biologicals.2017.08.008_bib119","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1086\/606119","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose","volume":"200","author":"McMahon","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.biologicals.2017.08.008_bib120","doi-asserted-by":"crossref","first-page":"e1500","DOI":"10.1542\/peds.2013-2940","article-title":"Duration of protection after infant hepatitis B vaccination series","volume":"133","author":"Middleman","year":"2014","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib121","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1017\/ice.2015.6","article-title":"Response to challenge dose among young adults vaccinated for hepatitis B as infants: importance of detectable residual antibody to hepatitis B surface antigen","volume":"36","author":"Spradling","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib122","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.23543","article-title":"Determination of immune memory to hepatitis B vaccination through early booster response in college students","volume":"51","author":"Jan","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biologicals.2017.08.008_bib123","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1086\/314768","article-title":"Hepatitis B vaccination in high-risk infants: 10-year follow-up","volume":"179","author":"Wu","year":"1999","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.biologicals.2017.08.008_bib124","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/hep.20490","article-title":"Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination","volume":"40","author":"Lu","year":"2004","journal-title":"Hepatology"},{"issue":"44","key":"10.1016\/j.biologicals.2017.08.008_bib125","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1016\/j.vaccine.2011.07.098","article-title":"Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination","volume":"29","author":"Zhu","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.biologicals.2017.08.008_bib126","first-page":"1","article-title":"CDC Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management","volume":"62","author":"CDC","year":"2013","journal-title":"MMWR"},{"key":"10.1016\/j.biologicals.2017.08.008_bib127","author":"WHO"},{"issue":"RR16","key":"10.1016\/j.biologicals.2017.08.008_bib128","first-page":"1","article-title":"A\u00a0comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part I: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"RR16","key":"10.1016\/j.biologicals.2017.08.008_bib129","first-page":"1","article-title":"A\u00a0comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"RR7","key":"10.1016\/j.biologicals.2017.08.008_bib130","first-page":"1","article-title":"Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). Advisory committee on immunization Practices","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.biologicals.2017.08.008_bib131","first-page":"317","article-title":"Recommendation of the immunization Practices Advisory Committee (ACIP): inactivated hepatitis B virus vaccine","volume":"31","author":"CDC","year":"1982","journal-title":"MMWR"},{"key":"10.1016\/j.biologicals.2017.08.008_bib132","author":"WHO"},{"key":"10.1016\/j.biologicals.2017.08.008_bib133","unstructured":"CDC. Adapted from a figure provided by John ward, head, hepatitis division, updated through 2015."},{"key":"10.1016\/j.biologicals.2017.08.008_bib134","author":"CDC"},{"issue":"09","key":"10.1016\/j.biologicals.2017.08.008_bib135","first-page":"220","article-title":"Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term care facilities \u2013 Mississippi, North Carolina and Los Angeles County, California - 2003-2004","volume":"54","author":"CDC","year":"2005","journal-title":"MMWR"},{"issue":"2","key":"10.1016\/j.biologicals.2017.08.008_bib136","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.28109","article-title":"Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: national Health and Nutrition Examination survey (NHANES), 1988-2012","volume":"63","author":"Roberts","year":"2016","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biologicals.2017.08.008_bib137","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib138","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2007.02.055","article-title":"Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies","volume":"132","author":"Ni","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib139","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jhep.2012.05.021","article-title":"Minimization of hepatitis B infection by a 25-year universal vaccination program","volume":"57","author":"Ni","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.biologicals.2017.08.008_bib140","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cgh.2016.04.030","article-title":"Continuing decrease in hepatitis B virus infection 30 years after initiation of infant vaccination program in Taiwan","volume":"14","author":"Ni","year":"2016","journal-title":"Clin Gastro Hepatol"},{"issue":"19","key":"10.1016\/j.biologicals.2017.08.008_bib141","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/jnci\/djp288","article-title":"Decreased incidence of hepatocellular carcinoma in hepatitis B vaccines: a 20-year follow-up study","volume":"101","author":"Chang","year":"2009","journal-title":"J\u00a0Nat Cancer Inst"},{"issue":"3","key":"10.1016\/j.biologicals.2017.08.008_bib142","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2016.05.048","article-title":"Long-term effects of hepatitis B immunization of infants in preventing liver cancer","volume":"151","author":"Chang","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biologicals.2017.08.008_bib143","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.20006","article-title":"Pediatric fulminant hepatic failure in endemic areas of hepatitis B virus infection: 15 years after universal hepatitis B vaccination","volume":"39","author":"Chen","year":"2004","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biologicals.2017.08.008_bib144","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/infdis\/jir852","article-title":"Effect of age on the incidence of acute hepatitis B after 25 years of universal newborn hepatitis B immunization program in Taiwan","volume":"205","author":"Su","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.biologicals.2017.08.008_bib145","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","article-title":"Epidemiology of hepatitis B virus infection and impact of vaccination on disease","volume":"20","author":"Nelson","year":"2016","journal-title":"Clin Liver Dis"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105617301033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105617301033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T11:32:53Z","timestamp":1692963173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105617301033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":145,"alternative-id":["S1045105617301033"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2017.08.008","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eradicating hepatitis B virus: The critical role of preventing perinatal transmission","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2017.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}